| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fibrogen Inc (KYNB) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. KYNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.0K | $418.2K | - | |
| CFO | 26.0K | $181.2K | - | |
| Dir | 7.0K | $48.8K | - | |
| Dir | 7.0K | $48.8K | - | |
| Dir | 7.0K | $48.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2017 | Riggs Rory B67 | Director | Sell | 25,000 | $51.92 | $1,298,000.00 | -5.4% | |
| Sep 11, 2017 | Cotroneo Pat | VP, Finance And CFO | Sell | 2,851 | $49.45 | $140,981.95 | -1.8% | |
| Sep 1, 2017 | Routti Jorma | Director | Sale+OE | 12,000 | $47.36 | $568,260.00 | -4.5% | |
| Aug 29, 2017 | Neff Thomas B | Chief Executive Officer | Sale+OE | 38,636 | $43.73 | $1,689,444.32 | -0.4% | |
| Aug 21, 2017 | Yu K Peony | Chief Medical Officer | Sell | 7,500 | $41.03 | $307,725.00 | -3.8% | |
| Aug 8, 2017 | Cotroneo Pat | VP, Finance And CFO | Sale+OE | 95,000 | $50.61 | $4,808,038.02 | -14.1% | |
| Aug 8, 2017 | Yu K Peony | Chief Medical Officer | Sale+OE | 37,500 | $50.58 | $1,896,861.00 | -8.5% | |
| Aug 2, 2017 | Cotroneo Pat | VP, Finance And CFO | Sale+OE | 28,346 | $33.97 | $962,964.98 | -8.0% | |
| Aug 1, 2017 | Yu K Peony | Chief Medical Officer | Sale+OE | 10,000 | $33.48 | $334,800.00 | -4.4% | |
| Jul 25, 2017 | Neff Thomas B | Chief Executive Officer | Sale+OE | 38,636 | $35.09 | $1,355,745.60 | -0.6% |